ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Mitral valve disease

In Global News: Long-Term Fontan Circulation, a Shock Team, and the TMVR Learning Curve

Patient Care and General Interest

The American Heart Association published a statement advocating for a holistic care approach for patients with Fontan circulation, noting that these patients are living longer and their unique long-term care needs are being better understood.

Abbott Receives U.S. Approval of Next-Generation MitraClip®

Abbott announced that its fourth-generation MitraClip device, MitraClip G4, was approved by the US Food and Drug Administration on July 15, 2019, to treat mitral regurgitation (MR) in a wider population of patients.  The MitraClip G4 include new clip sizes and an enhanced leaflet grasping feature

Pages

Subscribe to RSS - Mitral valve disease